A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in ...

The chemokine receptors CCR5 and CXCR4 are the two major coreceptors for HIV entry. Numerous efforts have been made to develop a new class of anti-HIV agents that target these coreceptors as an ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

HOUSTON, Texas (KTRK) -- The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, ...

Over the past three decades, there have been amazing advances in treating and preventing HIV. Subscribe to our newsletter for the latest sci-tech news updates. It's now a manageable infection. A ...

The Food and Drug Administration has just approved a preventative HIV drug widely regarded as a breakthrough. On Wednesday afternoon, the FDA approved Gilead Sciences’ lenacapavir as a more convenient ...

Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...

Coinfection of HIV and HCV leads to worse outcomes, necessitating effective HCV treatment in this population. Direct-acting antivirals show over 95% efficacy, yet HCV clearance rates in coinfected ...

Brown researchers will look into how a drug originally developed to treat HIV may reduce age-related inflammation.

Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...

More than half a million people previously diagnosed with HIV have started on HIV treatment since the end of February, the health minister says. But can a big jump in 10 weeks really be? We look at ...